ANTENGENE CORPORATION
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research and drug production, enabling physicians to meet unmet medical needs in Asia.
ANTENGENE CORPORATION
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.antengene.com
Total Employee:
251+
Status:
Active
Contact:
+86 21 3250 1095
Total Funding:
238 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen COVID-19 China Telecom
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Life Biosciences
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Novogene
Novogene is a provider of genomic services and solutions with cutting edge NGS.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Sphere Fluidics
Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hillhouse Investment
Hillhouse Investment investment in Series C - Antengene Corporation
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Antengene Corporation
GIC
GIC investment in Series C - Antengene Corporation
Boyu Capital
Boyu Capital investment in Series C - Antengene Corporation
Fidelity
Fidelity investment in Series C - Antengene Corporation
Taikang Insurance Group
Taikang Insurance Group investment in Series B - Antengene Corporation
FountainVest Partners
FountainVest Partners investment in Series B - Antengene Corporation
Boyu Capital
Boyu Capital investment in Series B - Antengene Corporation
TF Capital
TF Capital investment in Series B - Antengene Corporation
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Antengene Corporation
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-07 | Antengene Appoints Amily Zhang as its Chief Medical Officer |
Official Site Inspections
http://www.antengene.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.59 K
- Host name: 47.251.27.98
- IP address: 47.251.27.98
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Antengene Corporation"
Antengene Corporation - Crunchbase Company Profile …
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug …See details»
德琪医药 - Antengene
“ 网站 ”指德琪医药的网站，可从 antengene.c n 进入。 “ 您 ” 指访问或使用本服务的个人，或该个人所代表的法律实体（如适用）。 2. 确认和声明. 2.1 本条款和条件规定了本服务的使用 条件 …See details»
Antengene - LinkedIn
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, …See details»
Antengene Corporation - Funding, Financials, Valuation & Investors
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Antengene Corporation - Craft
Antengene Corporation is a clinical-stage biopharmaceutical company that develops drugs for cancer treatment. The Company is focused on drug discovery, clinical development and the …See details»
Antengene - VentureRadar
Antengene is a leading clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. We distinguish ourselves through our industry-leading R&D …See details»
Antengene Corp Ltd, 6996:HKG profile - FT.com - Financial Times
Nov 7, 2024 Antengene Corp Ltd is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the …See details»
About Antengene
Service Provider means any third party that processes Personal Information under the instructions of Antengene or to which Antengene discloses information for use on Antengene’s behalf. …See details»
Antengene Corporation, an Innovative Cancer Biotech Company, is …
Nov 20, 2020 Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a biopharmaceutical company with an integrated drug discovery and clinical development …See details»
Antengene Corporation Limited
2 Antengene Corporation Limited CORPORATE INFORMATION BOARD OF DIRECTORS Executive Directors Dr. Jay Mei (Chairman and Chief Executive Officer) Mr. John F. Chin …See details»
Antengene Announces 2021 Full Year Financial Results and …
Mar 18, 2022 Planning 2 INDs per Year (Antengene has global rights): Antengene has developed a vibrant, productive R&D team. 2022 IND Candidates : Antengene plans to submit …See details»
Antengene Corporation Closes US$97 Million Series C Financing to ...
Jul 20, 2020 Antengene is a biopharmaceutical company with integrated drug discovery, clinical development, manufacturing and commercialization anchored in the Asia Pacific regions and …See details»
Antengene Corporation Limited (6996.HK) - Yahoo Finance
Find the latest Antengene Corporation Limited (6996.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Chinese biotech start-up Antengene plans Hong Kong IPO, …
Jan 23, 2020 Chinese cancer drugs developer Antengene is eyeing a stock market listing in Hong Kong this year to fund the commercial launch in China of a new medicine and further …See details»
Antengene Presents Results from Three Investigational Programs …
Nov 6, 2024 Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, …See details»
Antengene Announces the Study of Anti-CD24 Monoclonal …
Dec 11, 2023 Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, …See details»
Newsroom - antengene.com
Antengene is a China-and-U.S. based biopharmaceutical company focusing on drug discovery, clinical development and the commercialization of innovative therapeutics to meet unmet …See details»
Working at Antengene - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Antengene, including salaries, reviews, office photos, and more. This is the Antengene company profile. All content is posted …See details»
R&D - Antengene
Antengene's global rights assets include the Claudin 18.2 targeted antibody-drug conjugate (ADC), ATG-022; the CD73 inhibitor, ATG-037; the PD-L1/4-1BB bispecific antibody, ATG …See details»